<?xml version="1.0" encoding="UTF-8"?>
<p>The FF100 study has been described in detail (
 <xref ref-type="bibr" rid="R15">15</xref>,
 <xref ref-type="bibr" rid="R16">16</xref>). This study was a prospective investigation of the first laboratory-confirmed cases and patientsâ€™ household contacts to determine key parameters such as virologic and clinical secondary attack rates (SARs) and effectiveness of AVs.
</p>
